BASIC FACTS
DATE OF LAUNCH
18 OCTOBER 2007
CATEGORY
EQUITY
TYPE
SMALL CAP
AUM*
Rs.6,510 crore
BENCHMARK
NIFTY SMALLCAP 250
TOTAL RETURN INDEXWHAT IT COSTS
NAV**
GROWTH OPTION
Rs.65.2
IDCW**
Rs.31.68
MINIMUM INVESTMENT
Rs.5,000
MINIMUM SIP AMOUNT
Rs.100
EXPENSE RATIO# (%)
1.82
1% for redemption
within 365 days
#AS ON 31 JULY 2023
*AS ON 31 JULY 2023
**AS ON 23 AUGUST 2023
Recent portfolio changes
New entrants
Cyient DLM, Sansera Engineering, TD Power Systems, Vijaya Diagnostic Centre (June). Supreme Petrochem (July).
Increasing allocation
Blue Star, FDC, PVR Inox, V-Mart Retail (June). Astec Lifesciences, Cyient DLM, Cyient, Orient Electric, PVR Inox, Sagar Cements (July).
Should You Buy
Amid the industry-wide re-categorisation exercise in 2018, this fund was repositioned from its earlier market-cap neutral, partdomestic and part-overseas equities avatar, under ICICI Pru India Asia Equity fund, to its current small-cap mandate. Under the new mandate, the fund has a portfolio balanced between quality compounders and normalcy candidates on the path to recovery. The fund consciously remains almost exclusively small cap, differentiating itself from peers taking sizeable exposure to mid or large caps. This makes it a true-to-label small-cap offering, potentially lending more fire power in favourable conditions, while acting as a drag on the downside. Its track record under the revised mandate is very limited. While it has struggled in the past year, it has exhibited healthy outperformance over three and five years. Aggressive investors seeking pure-play small cap exposure may consider this fund.
